The effects of streptozotocin-induced diabetes and of insulin supplementation to diabetic rats on glycogen-metabolizing enzymes in liver were determined. The results were compared with those from control animals. The activities of glycogenolytic enzymes, i.e. phosphorylase (both a and b), phosphorylase kinase and protein kinase (in the presence or in the absence of cyclic AMP), were significantly decreased in the diabetic animals. The enzyme activities were restored to control values by insulin therapy. Glycogen synthase (I-form) activity, similarly decreased in the diabetic animals, was also restored to control values after theadministration ofinsulin. The increase in glycogensynthase (I-form) activity after insulin treatment was associated with a concomitant increase in phosphoprotein phosphatase activity. The increase in phosphatase activity was due to (i) a change in the activity of the enzyme itself and (ii) a decrease in a heat-stable protein inhibitor of the phosphatase activity.
The effects of streptozotocin-induced diabetes and of insulin supplementation to diabetic rats on glycogen-metabolizing enzymes in liver were determined. The results were compared with those from control animals. The activities of glycogenolytic enzymes, i.e. phosphorylase (both a and b), phosphorylase kinase and protein kinase (in the presence or in the absence of cyclic AMP), were significantly decreased in the diabetic animals. The enzyme activities were restored to control values by insulin therapy. Glycogen synthase (I-form) activity, similarly decreased in the diabetic animals, was also restored to control values after theadministration ofinsulin. The increase in glycogensynthase (I-form) activity after insulin treatment was associated with a concomitant increase in phosphoprotein phosphatase activity. The increase in phosphatase activity was due to (i) a change in the activity of the enzyme itself and (ii) a decrease in a heat-stable protein inhibitor of the phosphatase activity.
Several studies have suggested that control of glycogen metabolism in liver is regulated by a cascade enzyme system that is similar to the one already established in skeletal muscle (Krebs, 1972; Hers, 1976) . Glucagon and adrenaline stimulate the formation of active phosphorylase a (EC 2.4.1.1) (Sutherland & Cori, 1951; Sutherland, 1951) and convert glycogen synthase (EC 2.4.1.11) from a glucose 6-phosphate-independent (I) form into a glucose 6-phosphate-dependent (D) form (Larner & Villar-Palasi, 1971; Stalmans & Hers, 1973) . Insulin, on the other hand, converts glycogen synthase from a glucose 6-phosphate-dependent form into a glucose 6-phosphate-independent form, both in vivo and in vitro (Steiner & King, 1964; Mersmann & Segal, 1967; Gold & Segal, 1967; Bishop & Larner, 1967; Kreutner & Goldberg, 1967; DeWulf & Hers, 1968) . Bishop & Larner (1967) further showed that insulin not only activates liver glycogen synthase, but also inactivates phosphorylase. Gold (1970) and Tan & Nuttall (1976) suggested that insulin has a direct effect on the synthase-activating enzyme. Furthermore, it is still controversial whether the insulin effect is mediated by cyclic AMP or by some unknown 'second' messenger (Hers, 1976) .
In the present study the effects of streptozotocininduced diabetes and of insulin treatment of these diabetic rats on liver glycogen metabolism have been examined. The enzymes involved in the regulation of glycogen synthesis, as well as in its degradation, have been examined in three groups of animals, i.e. con- The criteria used to assess the severity of the diabetic state have been described in detail (Howland & Zebrowski, 1974) . Urine glucose concentrations were measured daily with Tes Tape (Eli Lilly and Co., Indianapolis, IN, U.S.A.). Within 24h of streptozotocin treatment, all animals showed at least 2% (w/v) glucose in urine, and, with the exception of the 12 rats that received insulin therapy, all of the treated rats maintained this extent of glycosuria for the duration of the 40-day experiment. Protamine zinc insulin (Connaught Laboratories, Toronto, Ont., Canada) was administered by intraperitoneal injection each morning at the same time for only the last 7 days of the experiment to 12 randomly selected diabetic rats in an amount (5-28 i.u.) that was adequate to maintain their urine glucose concentrations below 0.1 %. Blood samples were drawn by heart puncture under ether anaesthesia on the last day of the experiment for serum glucose (non-starved) determination. Livers were removed immediately and quickly frozen by being placed between two slabs of solid CO2. These livers were stored at -70°C until further processed.
Preparation of liver homogenates
For all of the enzyme assays in this study except phosphatase, frozen rat livers were homogenized with 4vol. of 20mM-Tris/HCl (pH7.4) containing 0.25M-sucrose, 4mM-EDTA, 0.5imM-dithiothreitol and 50mM-NaF. For the phosphatase assay, rat livers were homogenized in the same buffer, but without NaF. The homogenates were centrifuged at 8000g for 30min and the supernatants collected after filtration through glass-wool and four layers of cheesecloth. The supernatants were then either extensively diluted (up to 200-fold) Phosphorylase a and total phosphorylase (a plus b) activities were determined by the method of Tan & Nuttall (1975) . The reaction mixture for the assay of phosphorylase a contained 33 mM-Mes buffer, pH6.3, 15mM-glucose 1-phosphate with tracer amounts of [14C]glucose 1-phosphate (pH6.3), 3.4mg of rabbit liver glycogen/ml, 5 mM-AMP, 150mM-NaF and properly diluted liver extract in a total volume of 0.1 ml. For the measurement of total phosphorylase activity, the assay mixture was the same as above except that glucose 1-phosphate and glycogen concentrations were raised to 273mM and 13.4mg/ml respectively. The incubation period was 10min at 30°C. The radioactive glycogen was precipitated on a Whatman 31ET paper, washed and counted for radioactivity as described by Reimann et al. (1971) (Brostrom et al., 1971) of the method originally described by Krebs et al. (1964) . The activity of this phosphorylase a was measured in the direction of glycogen synthesis by the method of Cori et al. (1943) . One unit of phosphorylase kinase activity was defined as the amount of enzyme that converted 1 unit of phosphorylase b into phosphorylase a/min. Phosphoprotein phosphatase activity was determined by using 32P-labelled phosphorylase a and phosphorylated histone as substrates, as described previously (Khandelwal et al., 1976) . One unit of phosphoprotein phosphatase activity was defined as the amount of enzyme that released 1 nmol of 32P, from 32P-labelled substrates/min. Phosphoprotein phosphatase inhibitor activity was determined by its ability to inhibit the dephosphorylation of 32P-labelled phosphorylase a. The reaction mixture contained 50mM-Tris/HCl buffer, pH7.5, 0.5mM-dithiothreitol, 0.4mg of bovine serum albumin, 1 mM-caffeine, 0.5mg of 32P-labelled phosphorylase a/ml, phosphoprotein phosphatase and inhibitor preparations in a total volume of 50jul.
The amount of phosphatase used per assay was In all assays, the incubation was carried out at 30°C for 30min and the released 32p1 was separated and counted for radioactivity as described previously (Khandelwal et al., 1976) . One unit of inhibitor activity was defined as the amount that would inhibit 20% dephosphorylation of 32P-labelled phosphorylase a under the stated conditions.
Analytical methods
Serum glucose was determined by the glucose oxidase method (Glucostat; Worthington Biochemical Corp., Freehold, NJ, U.S.A.). Liver glycogen was determined by the anthrone method as described by Sandham & Kleinberg (1969 Reynafarje & Lehninger (1969) .
Results and Discussion Bloodglucose andliver glycogen concentrations The blood glucose and liver glycogen concentrations in control, streptozotocin-induced-diabetic and insulin-treated diabetic animals are shown in Table 1 . Diabetic animals showed about a 4-fold higher blood glucose concentration and about a 3-fold decrease in liver glycogen concentration compared with control or insulin-treated diabetic animals. No significant difference was observed between control and insulin-treated diabetic animals.
Phosphorylase activities
The decrease in liver glycogen content in diabetic animals could be due to either the inhibition of glycogenesis or the activation of glycogenolysis. The enzymes that regulate the above processes are glycogen synthase for glycogenesis and phosphorylase for glycogenolysis. The activity of phosphorylase in the livers ofthe three groups of animals is shown in Table 2 . Phosphorylase a activity as well as total phosphorylase (a plus b) activity was significantly lower in diabetic animals than in the control or insulin-treated diabetic animals. No significant difference between the control and the insulin-treated diabetic groups was found. Phosphorylase a as a percentage of total phosphorylase was not altered by any of the experimental treatments. These results on phosphorylase are not in agreement with the reported observations in adipose tissue (Jungas, 1966) or in liver (Bishop & Larner, 1967) , in which insulin actually inactivated phosphorylase activity. However, there were two basic differences between our experimental conditions and those used by these earlier workers. First, they were determining the effects of insulin in normal animals, whereas in the present study diabetic animals were utilized. Secondly, these other workers determined only the short-term (in minutes) effects of insulin. In comparison we have determined the long-term (in days) effects of insulin. The possibility also exists that differences could be due to some direct effect of streptozotocin on the liver, which would not have been seen in the previous studies in normal rats. Torres et al. (1968) did not observe any effect of insulin on skeletal-muscle phosphorylase in normal rats.
Protein kinase andphosphorylase kinase activities
To determine whether the decreased activities of liver phosphorylase in diabetic animals were due to a decrease in the activities of phosphorylase kinase and/or of protein kinase, the activities of these two latter enzymes were determined in the three groups of animals. The activities of protein kinase, whether measured in the presence or in the absence of cyclic AMP, and the activity of phosphorylase kinase, were both significantly lower in diabetic animals than in the other two groups (Table 3) . No significant differences in protein kinase and phosphorylase kinase activities were found between the control and the insulin-treated groups. This general trend of decline in glycogenolytic enzymes in diabetic animals is perhaps due to either the inhibition of glycogenolysis by the hyperglycaemic state of the animals or the retardation of glycogenolysis by some endogenous control that may be related to the markedly lower amounts ofliver glycogen in the diabetic animals.
Regulation ofglycogen synthase
Several observations suggest that insulin plays a direct role in the regulation of glycogenesis by regulating the conversion of a glucose 6-phosphate-dependent form into a glucose 6-phosphate-independent form of glycogen synthase (Steiner & King, 1964; Mersmann & Segal, 1967; Gold &Segal, 1967; Bishop & Larner, 1967; Kreutner & Goldberg, 1967; DeWulf & Hers, 1968; Gold, 1970; Larner & Villar-Palasi, 1971; Stalmans & Hers, 1973; Lawrence et al., 1977) . The activities ofthe glucose 6-phosphate-independent form and of total glycogen synthase were also determined in the present study, andarereportedinTable4. The activity of the glucose 6-phosphate-independent form of glycogen synthase was lower in the diabetic animals than in either the control or insulin-treated animals. Total glycogen synthase activity, on the other hand, was significantly higher in diabetic animals when the results are expressed per mg of tissue. Insulin-treated animals showed significant increases in glycogen synthase (I-form) activity and in total glycogen synthase activity compared with the control animals. Glycogen synthase (I-form) activity, as a percentage of total glycogen synthase activity, was also significantly lower in diabetic animals.
The decrease in the glycogen synthase (I-form) activity in diabetic livers could be due to either an increase in the phosphorylation of the enzyme by protein kinase, or a decreased rate of dephosphorylation of the enzyme by protein phosphatase. Bishop et al. (1971) have observed that insulin caused an increase in glycogen synthase activity in dog livers without any change in either cyclic AMP concen- Glinsmann & Mortimore (1968) , who showed that insulin antagonizes the effect of glucagon metabolism in perfused livers without any significant change in cyclic AMP concentration. Subsequently, Miller & Larner (1973) concluded, after examining the effect of insulin on hepatic glycogen synthesis by use of either diabetic or glucagon-stimulated normal rats, that insulin increases the formation of glycogen synthase (I-form) with a concomitant decrease in cyclic AMP-dependent glycogen synthase (protein) kinase activity. In the present study, the injection of insulin in diabetic rats caused an increase in the activity of protein kinase whether measured in the presence or in the absence of cyclic AMP (Table 3) . This increase might not be related to the activation of glycogen synthase, because under those circumstances one would expect a decrease in kinase activity. These results therefore would not indicate a direct role for protein kinase in the activation of glycogen synthase by insulin. However, one cannot rule out the possibility that a specific glycogen synthase (protein) kinase is involved in this process. The presence ofsuch a kinase has been reported in kidney (Reimann & Schlender, 1976) and in skeletal muscle (Huang et al., 1975) .
Involvement ofphosphoprotein phosphatase
The idea for the involvement of phosphatase in the insulin effect in glycogen synthesis evolved from the work of Bishop (1970) , who observed that the injection of insulin into dogs resulted in an activation of hepatic synthase phosphatase. The concentration of this synthase-activating enzyme was very low in alloxan-diabetic rat livers, and administration of insulin to these rats resulted in restoration of the enzyme to normal concentrations (Bishop & Larner, 1967; Gold, 1970 have also observed the activation of synthase phosphatase by insulin in the heart extracts of starved or diabetic Vol. 168 rats. In the present study, the activity of phosphoprotein phosphatase was determined by using exogenous as well as endogenous substrates. The activity ofthis enzyme with exogenous substrates phosphorylase a and phosphorylated histones is shown in Table 5 . Diabetic rats showed a significant decrease in phosphatase activity with both of the substrates tested when expressed per mg of protein. When the results were expressed per mg of tissue, no difference was found between the control and diabetic groups. The reason for this discrepancy is not clear, but it might be indicative of a change in the specific activity rather than total activity of the enzyme. Insulin-treated diabetic animals, however, showed a significant increase in phosphatase activity with substrate phosphorylase a, whether the activity was expressed per mg of protein or per mg of tissue. No significant difference was found between the control and insulin-treated animals for phosphatase activity when phosphorylated histone was the substrate.
The activity of phosphoprotein phosphatase was further determined by measuring the time-dependent change in the activities of endogenous phosphorylase a and glycogen synthase (D-form) by incubating the liver extracts at 23°C. As shown in Fig. 1 , the inactivation of phosphorylase a proceeded at a faster rate in liver tissue from the control and insulintreated animals. However, it is noteworthy that the activity of phosphorylase a in these two groups never decreased at any time during incubation to the low value shown by the diabetic animals. The differences in the rate ofinactivation ofphosphorylase a in these groups are obvious when the results are expressed in terms of percentage phosphorylase a activity (Fig. 1, inset) . Inactivation ofphosphorylase a proceeded at a lower rate in diabetic animals than in control or insulin-treated diabetic animals. There was no difference between the latter two groups. The activation of glycogen synthase (D-form) is shown in Fig. 2 . Like the inactivation of phosphorylase, the activation of glycogen synthase was also faster in Time of incubation (min) Fig. 1 . Inactivation of glycogen phosphorylase in liver extracts of control (a), streptozotocin-induced-diabetic (A) and insulin-treateddiabetic (EJ) rats in vitro Liver extracts were prepared as described in the Experimental section. The extracts were incubated at 23'C and samples were taken for determining the phosphorylase activity at the indicated times. In the inset, phosphorylase a activity is expressed as percentage of the total. Values are the means±s.E.M. for four livers in each group. Standard error bars have been omitted from the inset for clarity.
control and insulin-treated animals. After 1 h of incubation, the glycogen synthase (I-form) activity reached 80% of the total synthase activity in the control and insulin-treated rats, but only 35 % of the total synthase activity in the diabetic animals. The activities of phosphatase thus calculated are shown in Table 6 . The phosphatase activity in diabetic animals was 25-37 % of that in the other two groups. These results on phosphatase with exogenous and endogenous substrates would indicate a direct role of insulin in the activation of this enzyme. Time of incubation (min) Fig. 2 . Activation of glycogen synthase in liver extracts of control, streptozotocin-induced-diabetic and insulintreated diabetic rats in vitro Liver extracts were prepared as described in the Experimental section. The extracts were incubated at 23°C and samples were taken at the indicated times. Glycogen synthase activities are expressed in the presence (-, A, M) or in the absence (0, A, OI) of 10mM-glucose 6-phosphate in control (o, *), streptozotocin-induced-diabetic (A, A) and insulintreated (Dl, M) animals (a). The percentage of total activity as activated enzyme is shown in Fig. 2(b) . Enzyme assays are described in detail in the Experimental section. Values are the means±S.E.M. for four livers in each group. Standard-error bars have been omitted from the top three lines in Fig. 2(a) for clarity.
Phosphoprotein phosphatase inhibitor activities
A comparison of the phosphatase activities reported in Tables 5 and 6 (Brandt et al., 1975) .
To determine whether the quantitative differences in the decrease of phosphatase activity measured under these two sets ofconditions is due to a change in the concentration of heat-stable inhibitor, the Vol. 168 inhibitor activities were also measured in these three groups (Table 7) . A significant increase in inhibitor activity was observed in diabetic animals compared with the other two groups. The effect of different amounts of inhibitor prepared from all three groups on the inhibition of phosphatase activity is shown in Fig. 3 . As expected, the inhibitor prepared from diabetic livers showed the maximum inhibition. These results, along with those obtained on phosphatase activity, further indicate that the activation of phosphatase by insulin is partly due to the effect on the enzyme itself and partly due to the change in heatstable inhibitor of phosphoprotein phosphatase.
Other studies It has been suggested that insulin effects might be mediated through cyclic GMP (Illiano et al., 1973) . The addition of this nucleotide to the liver extracts in the present study had no effect on either phosphatase or its inhibitor activity. The other probable messenger for this hormone could be a cation, as hypothesized by Hers (1976) . The concentrations of four ofthe regulatory cations were therefore examined in the livers of control, diabetic and insulin-treated diabetic animals. Diabetic animals showed an approx. 20 % decrease in total tissue Ca2+ (Table 8) . 
